Tenet Reports Results for the Second Quarter Ended June 30, 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- European shares subdued as surging crude sharpens focus on ECB rate path
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Alibaba (BABA) PT Lowered to $165 at Bernstein SocGen Group
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Mizuho Securities Cuts Price Target on Tenet Healthcare (THC) to $28; Reiterates Neutral
August 2, 2016 8:11 AM EDTMizuho Securities maintained a Neutral rating on Tenet Healthcare (NYSE: THC), and cut the price target to $28.00 (from $33.00), following the company's 2Q earnings report.
Analyst Sheryl Skolnick commented, "The Mama issue is not a 'once and done, now it's behind them' thing. It's... More
Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance
August 1, 2016 5:18 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $4.87 billion versus the consensus estimate of $4.83 billion.
GUIDANCE:
Tenet Healthcare sees FY2016 EPS of $1.32-$1.67, versus the consensus of $1.93.... More
